• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[Clinical analysis of ascitic fluid in patients with liver cirrhosis and hepatocellular carcinoma].

作者信息

Takezaki E, Murakami S, Nishibayashi H, Kagawa K, Ohmori H

机构信息

Dept. of Gastroenterology, Kure National Hospital.

出版信息

Gan No Rinsho. 1990 Nov;36(14):2415-9.

PMID:1979086
Abstract

To investigate the clinical significance of ascitic fluid in patients with a malignancy, an abdominal paracentesis to evaluate the ascitic fluid was performed in 10 patients with a hepatocellular carcinoma (HCC) and in 7 patients with liver cirrhosis (LC). The AFP levels in the ascitic fluid and in the serum of the HCC patients was found be significantly higher than that of the LC patients. In addition, the ratio of albumin/total protein in ascitic fluid was also higher in the HCC patients. However, no significant findings were uncovered with regard to the concentration of lipid in ascitic fluid, in either type of patient although 2 HCC patients were found to have a very high concentration of total cholesterol. The cytological findings provided no reliable marker because of significant number of false negatives in the HCC patients. Also, there was no significant difference between the fibronectin levels in the ascitic fluid of either type of patients. This finding differs from previous studies, and suggests that the fibronectin levels in the ascitic fluid may not be a useful marker in determining a malignancy.

摘要

相似文献

1
[Clinical analysis of ascitic fluid in patients with liver cirrhosis and hepatocellular carcinoma].
Gan No Rinsho. 1990 Nov;36(14):2415-9.
2
Utility of ascitic fluid analysis in patients with malignancy-related ascites.恶性肿瘤相关性腹水患者腹水分析的效用
Scand J Gastroenterol. 1990 Mar;25(3):251-6.
3
Detection of soluble tumor necrosis factor-p55 levels in the serum and ascitic fluid of patients with hepatocellular carcinoma.
Di Yi Jun Yi Da Xue Xue Bao. 2002 Jul;22(7):641-3.
4
Alpha feto-protein and albumin in ascitic fluid in hepatocellular carcinoma patients.
J Egypt Soc Parasitol. 1997 Aug;27(2):455-64.
5
Diagnostic paracentesis. A two-step approach.诊断性腹腔穿刺术。两步法。
Ital J Gastroenterol. 1996 Feb-Mar;28(2):81-5.
6
Diagnosing ascitic etiology on a biochemical basis.基于生化指标诊断腹水病因。
Hepatogastroenterology. 1998 Sep-Oct;45(23):1673-7.
7
[Concentration of lipids in ascitic fluid and the concentration gradient of albumin in blood and ascites: diagnostic significance].[腹水脂质浓度及血液与腹水白蛋白浓度梯度:诊断意义]
Ann Gastroenterol Hepatol (Paris). 1989 Nov;25(6):251-6.
8
[Zinc in patients with ascites].[腹水患者体内的锌]
An Med Interna. 1989 Dec;6(12):624-8.
9
Transforming growth factor beta1 and soluble Fas serum levels in hepatocellular carcinoma.肝细胞癌中转化生长因子β1及可溶性Fas的血清水平
Cytokine. 2000 Jun;12(6):811-4. doi: 10.1006/cyto.1999.0650.
10
Plasma proteasome level is a reliable early marker of malignant transformation of liver cirrhosis.血浆蛋白酶体水平是肝硬化恶变的可靠早期标志物。
Gut. 2009 Jun;58(6):833-8. doi: 10.1136/gut.2008.157016. Epub 2009 Feb 6.